Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Seretide/Advair

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Seretide/Advair was produced by GlaxoSmithKline.

Boehringer posts solid first half as business revamp beds in

Boehringer posts solid first half as business revamp beds in

Meanwhile, the COPD category has been affected by the arrival of generics of big-selling brands like GlaxoSmithKline’s Advair (salmeterol/fluticasone propionate).

With Spiriva under pressure, Boehringer moves to bolster pipeline

With Spiriva under pressure, Boehringer moves to bolster pipeline delivery device – a factor that also held up generics to GlaxoSmithKline’s big-selling COPD drug Advair in the US.

Advair generics and acquisitions to hit GSK in 2019

Advair generics and acquisitions to hit GSK in 2019 However the company will feel the squeeze as it transforms in 2019, and has now advised that its profits will be hit by the arrival of Advair generics in the US ... The flat performance in pharma has been in part due to GSK discounting Advair (Seretide

GSK’s Advair Diskus faces first generic in US

GSK’s Advair Diskus faces first generic in US Mylan has finally muscled its generic of GlaxoSmithKline’s respiratory blockbuster Advair onto the US market, after a catalogue of delays. ... At the same time, Teva also launched an authorised generic of its own brand to try to eat further into

GSK upbeat on its return to oncology market

GSK upbeat on its return to oncology market GSK faces generic competition to its biggest seller, ageing respiratory treatment Advair, by the end of 2019, and analysts believe the company’s HIV franchise could decline thanks to competition from

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics